5 completed. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Completed 5 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyaluronidase Via LADD Scleroderma-induced Microstomia Hyaluronidase, CO2 laser - Microstomia, Scleroderma | Early Phase 1 | Completed | University of Nebraska | 3 | 2024-03-01 | 2026-04-15 |
| The Effects of Botulinum Toxin on Oral Aperture in Patients With Scleroderma Botulinum toxin(Botox) - Scleroderma | Early Phase 1 | Completed | University of Texas Southwestern Medical Center | 17 | 2020-05-08 | 2021-04-28 |
| Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients SVF injection - Systemic Sclerosis | Early Phase 1 | Completed | Suk-Ho Moon | 20 | 2018-07-01 | 2020-10-08 |
| Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud 10% nifedipine cream, 5% sildenafil cream - Raynaud Phenomenon Due to Trauma, Raynaud Disease | Early Phase 1 | Completed | Pontificia Universidad Catolica de Chile | 10 | 2016-08-01 | 2017-01-23 |
| Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) buspirone - Systemic Sclerosis | Early Phase 1 | Completed | Laikο General Hospital, Athens | 22 | 2014-12-01 | 2016-10-24 |
Scleroderma, Diffuse (3) · Dermatomyositis (1) · Lupus Erythematosus, Systemic (1) · Microstomia (1) · Raynaud Disease (1)
Connective Tissue Diseases (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Embolism and Thrombosis (1) · Immune System Diseases (1) · Livedoid Vasculopathy (1) · Mouth Abnormalities (1) · Mouth Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1)
Botulinum Toxins, Type A (1) · Buspirone (1) · Chondroitinases and Chondroitin Lyases (1) · Hyaluronoglucosaminidase (1) · Lasers, Gas (1) · Therapeutics (1)
Laikο General Hospital, Athens (1) · Pontificia Universidad Catolica de Chile (1) · Suk-Ho Moon (1) · University of Nebraska (1) · University of Texas Southwestern Medical Center (1)
United States (2) · Chile (1) · Greece (1) · South Korea (1)
Cristian Vera-Kellet, MD (1) · Georgios Karamanolis (1) · Heather Goff, MD (1) · Sarah L Lonowski, MD (1) · Seung-Ki Kwok (1) · Suk-Ho Moon, MD, PhD (1)